Human NK cells confer protection against HIV-1 infection in humanized mice

The role of NK cells against HIV-1 infections remains to be elucidated in vivo. While humanized mouse models potentially could be used to directly evaluate human NK cell responses during HIV-1 infection, improved functional development of human NK cells in these hosts is needed. Here, we report the...

Full description

Bibliographic Details
Main Authors: Can M. Sungur, Qiankun Wang, Ayşe N. Ozantürk, Hongbo Gao, Aaron J. Schmitz, Marina Cella, Wayne M. Yokoyama, Liang Shan
Format: Article
Language:English
Published: American Society for Clinical Investigation 2022-12-01
Series:The Journal of Clinical Investigation
Subjects:
Online Access:https://doi.org/10.1172/JCI162694
_version_ 1797634518258024448
author Can M. Sungur
Qiankun Wang
Ayşe N. Ozantürk
Hongbo Gao
Aaron J. Schmitz
Marina Cella
Wayne M. Yokoyama
Liang Shan
author_facet Can M. Sungur
Qiankun Wang
Ayşe N. Ozantürk
Hongbo Gao
Aaron J. Schmitz
Marina Cella
Wayne M. Yokoyama
Liang Shan
author_sort Can M. Sungur
collection DOAJ
description The role of NK cells against HIV-1 infections remains to be elucidated in vivo. While humanized mouse models potentially could be used to directly evaluate human NK cell responses during HIV-1 infection, improved functional development of human NK cells in these hosts is needed. Here, we report the humanized MISTRG-6-15 mouse model, in which NK cells were quick to expand and exhibit degranulation, cytotoxicity, and proinflammatory cytokine production in nonlymphoid organs upon HIV-1 infection but had reduced functionality in lymphoid organs. Although HIV-1 infection induced functional impairment of NK cells, antiretroviral therapy reinvigorated NK cells in response to HIV-1 rebound after analytic treatment interruption. Moreover, a broadly neutralizing antibody, PGT121, enhanced NK cell function in vivo, consistent with antibody-dependent cellular cytotoxicity. Monoclonal antibody depletion of NK cells resulted in higher viral loads in multiple nonlymphoid organs. Overall, our results in humanized MISTRG-6-15 mice demonstrated that NK cells provided direct anti–HIV-1 responses in vivo but were limited in their responses in lymphoid organs.
first_indexed 2024-03-11T12:09:54Z
format Article
id doaj.art-9b0131221adb45cb99de54bafcf1897f
institution Directory Open Access Journal
issn 1558-8238
language English
last_indexed 2024-03-11T12:09:54Z
publishDate 2022-12-01
publisher American Society for Clinical Investigation
record_format Article
series The Journal of Clinical Investigation
spelling doaj.art-9b0131221adb45cb99de54bafcf1897f2023-11-07T16:19:39ZengAmerican Society for Clinical InvestigationThe Journal of Clinical Investigation1558-82382022-12-0113224Human NK cells confer protection against HIV-1 infection in humanized miceCan M. SungurQiankun WangAyşe N. OzantürkHongbo GaoAaron J. SchmitzMarina CellaWayne M. YokoyamaLiang ShanThe role of NK cells against HIV-1 infections remains to be elucidated in vivo. While humanized mouse models potentially could be used to directly evaluate human NK cell responses during HIV-1 infection, improved functional development of human NK cells in these hosts is needed. Here, we report the humanized MISTRG-6-15 mouse model, in which NK cells were quick to expand and exhibit degranulation, cytotoxicity, and proinflammatory cytokine production in nonlymphoid organs upon HIV-1 infection but had reduced functionality in lymphoid organs. Although HIV-1 infection induced functional impairment of NK cells, antiretroviral therapy reinvigorated NK cells in response to HIV-1 rebound after analytic treatment interruption. Moreover, a broadly neutralizing antibody, PGT121, enhanced NK cell function in vivo, consistent with antibody-dependent cellular cytotoxicity. Monoclonal antibody depletion of NK cells resulted in higher viral loads in multiple nonlymphoid organs. Overall, our results in humanized MISTRG-6-15 mice demonstrated that NK cells provided direct anti–HIV-1 responses in vivo but were limited in their responses in lymphoid organs.https://doi.org/10.1172/JCI162694Immunology
spellingShingle Can M. Sungur
Qiankun Wang
Ayşe N. Ozantürk
Hongbo Gao
Aaron J. Schmitz
Marina Cella
Wayne M. Yokoyama
Liang Shan
Human NK cells confer protection against HIV-1 infection in humanized mice
The Journal of Clinical Investigation
Immunology
title Human NK cells confer protection against HIV-1 infection in humanized mice
title_full Human NK cells confer protection against HIV-1 infection in humanized mice
title_fullStr Human NK cells confer protection against HIV-1 infection in humanized mice
title_full_unstemmed Human NK cells confer protection against HIV-1 infection in humanized mice
title_short Human NK cells confer protection against HIV-1 infection in humanized mice
title_sort human nk cells confer protection against hiv 1 infection in humanized mice
topic Immunology
url https://doi.org/10.1172/JCI162694
work_keys_str_mv AT canmsungur humannkcellsconferprotectionagainsthiv1infectioninhumanizedmice
AT qiankunwang humannkcellsconferprotectionagainsthiv1infectioninhumanizedmice
AT aysenozanturk humannkcellsconferprotectionagainsthiv1infectioninhumanizedmice
AT hongbogao humannkcellsconferprotectionagainsthiv1infectioninhumanizedmice
AT aaronjschmitz humannkcellsconferprotectionagainsthiv1infectioninhumanizedmice
AT marinacella humannkcellsconferprotectionagainsthiv1infectioninhumanizedmice
AT waynemyokoyama humannkcellsconferprotectionagainsthiv1infectioninhumanizedmice
AT liangshan humannkcellsconferprotectionagainsthiv1infectioninhumanizedmice